Auxilium Biotechnologies, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Auxilium Biotechnologies, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Auxilium Biotechnologies, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 17, 2026 to Jan 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code JXI appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 333 Jackson Plz., Ann Arbor, MI, 48103, US. Recorded on K253363, decision dated Jan 17, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
NeuroSpan Bridge
K253363 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.